- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- February 2026
- 281 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 480 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 290 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 364 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 197 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 242 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 192 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 173 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- October 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- April 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- April 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- March 2025
- 175 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1756EUR$2,000USD£1,527GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1097EUR$1,250USD£955GBP

The Addiction Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat addiction disorders. These drugs are used to treat a variety of conditions, including alcohol and drug addiction, nicotine addiction, and gambling addiction. The market is composed of both generic and branded drugs, with the latter being more expensive.
The market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are constantly researching and developing new drugs to treat addiction disorders, as well as improving existing treatments. Additionally, many of these companies are involved in clinical trials to test the efficacy of their drugs. Show Less Read more